Partnership

Homepage - Torlak Institute

Messenger Biopharma has established a partnership with the Torlak Institute for the development of an mRNA vaccine against the West Nile Virus.

Last news

our-mrna-platform-page

Messenger Biopharma in Lyonbiopole’s newsletter

posted December 22, 2016

  Please click on this ...Read More